Belantamab Mafodotin Plus Cyclophosphamide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma: Interim Results from the UK Myeloma Research Alliance Prommise Clinical TrialRakesh Popat, Christopher Parrish, Robert Cicero et al.|Blood|2024Cited by 3